# Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes

> **NCT05207800** · — · UNKNOWN · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 180 (estimated)

## Conditions studied

- Preterm Premature Rupture of Membrane

## Interventions

- **OTHER:** The concentrations of PTX3 and HBP were monitored in maternal blood, placental tissue and amniotic fluid.

## Key facts

- **NCT ID:** NCT05207800
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-10
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2022-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05207800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05207800, "Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT05207800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*